Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2017	Jun. 30, 2016
Current assets:
Cash	$ 35,917	$ 170,194
Prepaid expenses	6,736	15,240
Subscription receivable		7,500
Deposits and other receivables	1,580	1,000
Total current assets	44,233	193,934
Property and equipment, net (Note 3)	2,752	4,259
Total assets	46,985	198,193
Current liabilities:
Accounts payable and accrued expenses	901,443	768,272
Deferred compensation (Note 4)	1,962,885	1,436,595
Convertible notes payable - affiliates (Note 6)	3,373,987
Loan payable and accrued interest (Note 5)	8,738,157	8,563,662
Total current liabilities	15,005,372	10,795,929
Convertible Notes Payable, Noncurrent		3,280,647
Total liabilities	15,005,372	14,076,576
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 24,324,576 and 23,573,057 shares issued, respectively; 23,620,267 and 22,868,748 shares outstanding, respectively
Additional paid-in capital	103,198,697	102,278,364
Subscription receivable - affiliate	(40,000)
Accumulated deficit	(118,174,926)	(116,216,493)
Total Bion's stockholders’ deficit	(15,016,229)	(13,938,129)
Noncontrolling interest	57,842	59,746
Total deficit	(14,958,387)	(13,878,383)
Total liabilities and deficit	46,985	198,193
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $31,500 and $30,000, respectively (Note 7)	28,900	27,400
Series A Preferred Stock [Member]
Deficit:
Series A Preferred stock, $0.01 par value, 10,000 shares authorized, Series C Convertible Preferred stock, $0.01 par value, 60,000 shares authorized; no shares issued and outstanding